Please assess the completion status of the following clinical trial:

Trial Title: Increasing Use of Continuous Glucose Monitors in Publicly-insured Youth With Type 1 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* type 1 diabetes for more than 6 months~* on insulin pump or multiple daily injections without plans to change modality in next 6 months~* insured by CCS or Medi-Cal~* receiving care at Lucile Packard Children's Hospital or Stanford Children's Health outpatient clinics~* English or Spanish-speaking~Exclusion Criteria:~* major illness or condition that may alter glucose control or ability to complete the study including pregnancy, cystic fibrosis, cancer, liver disease, history of transplant, or hemoglobinopathy~* current oral glucocorticoid use~* prior use of a CGM system~* hemoglobin A1C \<7.5% or \>12%~* no wireless internet access

- Gender: ALL
- Minimum Age: 13 Years
- Maximum Age: 19 Years
- Healthy Volunteers: f

Study Arms:
- Gamification (Type: EXPERIMENTAL): Use of continuous glucose monitor (Dexcom G5) with proactive intervention and incentives for time in use.
- Standard care (Type: ACTIVE_COMPARATOR): Use of continuous glucose monitor (Dexcom G5) per usual care.

Based on this trial design, predict the completion outcome and termination type (if applicable).